Application 213981

Type
ANDA
Sponsor
ZYDUS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BOSENTANBOSENTANTABLET, FOR SUSPENSION;ORAL32MGNoNo

Orange Book products#

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213981-001BOSENTANBOSENTAN32MGTABLET, FOR SUSPENSION / ORALAB2026-02-17

Therapeutic equivalence codes#

Application-product, TE code table
Application-productTE code
A213981-001AB

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bosentanBOSENTANZydus Lifesciences Limitedb88cc559-93ae-42db-9c38-fb5e9c4802e62026-02-14Exact identifier
bosentanBOSENTANZydus Pharmaceuticals USA Inc.c1e75179-cbea-4535-8709-f6d79c1d40042025-11-12Boxed warning, Warnings, Adverse reactionsExact identifier